CollPlant Biotechnologies (CLGN) Net Cash Flow (2018 - 2025)

CollPlant Biotechnologies' Net Cash Flow history runs 8 years deep, the most recent figure standing at -$2.9 million for Q4 2025.

• Quarterly Net Cash Flow rose 16.24% year-over-year to -$2.9 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$8.3 million (up 26.79% YoY) and the FY2025 annual result came in at -$6.3 million, up 56.62% from the prior year.
• Net Cash Flow was -$2.9 million for Q4 2025 at CollPlant Biotechnologies, down from -$2.9 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $28.1 million in Q1 2022 and bottomed at -$33.8 million in Q4 2021.
• A 5-year average of -$1.6 million and a median of -$2.9 million in 2025 frame the typical range for Net Cash Flow.
• Peak annual rise in Net Cash Flow reached 794.62% in 2021, while the deepest fall reached 579.94% in 2021.
• CollPlant Biotechnologies' Net Cash Flow stood at -$33.8 million in 2021, then jumped by 59.8% to -$13.6 million in 2022, then soared by 80.02% to -$2.7 million in 2023, then declined by 29.63% to -$3.5 million in 2024, then grew by 16.24% to -$2.9 million in 2025.
• Business Quant data shows CLGN's Net Cash Flow at -$2.9 million in Q4 2025, -$2.9 million in Q3 2025, and -$2.4 million in Q2 2025.